IP Library › Granted Patent US 9,468,764
Granted Patent B2
US 9,468,764 · App. 14/165,239 · Granted Oct 18, 2016

Nerve signal differentiation in cardiac therapy

Inventors: Xiaochong Zhou (Woodbury, MN); John Edward Burnes (Coon Rapids, MN); Lilian Kornet (Maastricht, NL); Richard N. M. Cornelussen (Maastricht, NL)
Assignee: Medtronic, Inc.
A61N1/36139A61N1/36053A61N1/36114A61N1/36514
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,468,764
App. No.
14/165,239
Granted
Oct 18, 2016
Kind
B2
Abstract

Methods of nerve signal differentiation, methods of delivering therapy using such nerve signal differentiation, and to systems and devices for performing such methods. Nerve signal differentiation may include locating two electrodes proximate nerve tissue and differentiating between efferent and afferent components of nerve signals monitored using the two electrodes.

Claims (41)

1. An implantable medical device for delivering cardiac therapy comprising:

monitoring apparatus configured to monitor physiological parameters of a patient, wherein the monitoring apparatus comprises at least two electrodes configured to monitor electrical activity of the patient's vagus nerve;

a sensing module operably coupled to the monitoring apparatus and configured to receive the monitored physiological parameters;

a therapy delivery module configured to deliver cardiac therapy to the patient;

control module operably coupled to the sensing module and to the therapy delivery module and configured to:

differentiate between efferent activity and afferent activity of the monitored electrical activity of the patient's vagus nerve,

analyze the monitored physiological parameters by at least determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time, and

initiate or adjust cardiac therapy to the patient if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the control module is further configured to:

determine whether the monitored electrical activity of the patient's vagus nerve comprises afferent activity, and

determine whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced by at least comparing the efferent activity to the afferent activity.

2. An implantable medical device for delivering cardiac therapy comprising:

monitoring apparatus configured to monitor physiological parameters of a patient, wherein the monitoring apparatus comprises at least two electrodes configured to monitor electrical activity of the patient's vagus nerve;

a sensing module operably coupled to the monitoring apparatus and configured to receive the monitored physiological parameters;

a therapy delivery module configured to deliver cardiac therapy to the patient;

control module operably coupled to the sensing module and to the therapy delivery module and configured to:

differentiate between efferent activity and afferent activity of the monitored electrical activity of the patient's vagus nerve,

analyze the monitored physiological parameters by at least determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time, and

initiate or adjust cardiac therapy to the patient if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the control module is configured to determine whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced by at least comparing the average amplitude of a selected frequency range of the efferent activity to a selected value.

3. An implantable medical device for delivering cardiac therapy comprising:

monitoring apparatus configured to monitor physiological parameters of a patient, wherein the monitoring apparatus comprises at least two electrodes configured to monitor electrical activity of the patient's vagus nerve;

a sensing module operably coupled to the monitoring apparatus and configured to receive the monitored physiological parameters;

a therapy delivery module configured to deliver cardiac therapy to the patient;

control module operably coupled to the sensing module and to the therapy delivery module and configured to:

differentiate between efferent activity and afferent activity of the monitored electrical activity of the patient's vagus nerve,

analyze the monitored physiological parameters by at least determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time, and

initiate or adjust cardiac therapy to the patient if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the control module is configured to determine whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced by at least comparing the average amplitude of a selected frequency range of the presently-monitored efferent activity to the average amplitude of the selected frequency range of previously-monitored efferent activity.

4. An implantable medical device for delivering cardiac therapy comprising:

monitoring apparatus configured to monitor physiological parameters of a patient, wherein the monitoring apparatus comprises at least two electrodes configured to monitor electrical activity of the patient's vagus nerve;

a sensing module operably coupled to the monitoring apparatus and configured to receive the monitored physiological parameters;

a therapy delivery module configured to deliver cardiac therapy to the patient;

control module operably coupled to the sensing module and to the therapy delivery module and configured to:

differentiate between efferent activity and afferent activity of the monitored electrical activity of the patient's vagus nerve,

analyze the monitored physiological parameters by at least determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time, and initiate or adjust cardiac therapy to the patient if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the control module is configured to determine whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced by at least comparing the average power of a selected frequency range of the efferent activity to a selected value.

5. An implantable medical device for delivering cardiac therapy comprising:

monitoring apparatus configured to monitor physiological parameters of a patient, wherein the monitoring apparatus comprises at least two electrodes configured to monitor electrical activity of the patient's vagus nerve;

a sensing module operably coupled to the monitoring apparatus and configured to receive the monitored physiological parameters;

a therapy delivery module configured to deliver cardiac therapy to the patient;

control module operably coupled to the sensing module and to the therapy delivery module and configured to:

differentiate between efferent activity and afferent activity of the monitored electrical activity of the patient's vagus nerve,

analyze the monitored physiological parameters by at least determining whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced over time, and

initiate or adjust cardiac therapy to the patient if the efferent activity of the electrical activity of the patient's vagus nerve is reduced, wherein the control module is configured to determine whether the efferent activity of the electrical activity of the patient's vagus nerve is reduced by at least comparing the average power of a selected frequency range of the presently-monitored efferent activity to the average power of the selected frequency range of previously-monitored efferent activity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2014
From: ZHOU, XIAOHONG; BURNES, JOHN EDWARD; KORNET, LILIAN; CORNELUSSEN, RICHARD N.M.
To: MEDTRONIC, INC.
Reel/Frame 032814/0359 →
Continuity (3)
Division 12848019 · Jul 30, 2010
Provisional Application 61397702 · Apr 29, 2010
Related Publication 20140142650A1 · May 22, 2014